|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.74/-1.80
|
企業價值
15.41M
|
資產負債 |
每股賬面淨值
0.87
|
現金流量 |
現金流量率
--
|
損益表 |
收益
6.99M
|
每股收益
0.27
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/17 01:28 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities. |